• For Individuals
  • For Institutions
  • Download
  • Help
  • About

longbridgelongbridge
longbridgelongbridge
Why Longbridge?
Investment Products
Trading Tools
Trading Platform
Developers
Market Data Services
Analysis Tools
News Services
Dolphin Research
Pricing
Markets
Global Markets
Stock Screener
Information
Research
News
Live
Community
Academy
Promotions
PortAI
LB Café
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
Posts
News
Financials
© 2025 Longbridge|Disclaimer

Event Tracking

Nov25
Annavik Life Sciences Reports No Revenue in FY2025, Cash and Operating Funds Decline
21:33
Anavex Life Science released FY2025 Annual Earnings on November 25 During-Market (EST), actual revenue USD 0 (forecast USD 0), actual EPS USD -0.5437 (forecast USD -0.5766)
21:00
Anavex Life Science released FY2025 Q4 earnings during market hours on November 25 (EST), actual revenue USD 0 (forecast USD 0), actual EPS USD -0.1144 (forecast USD -0.15)
21:00
Nov19
Anavex Life Sciences Corp. is a biopharmaceutical company focused on developing innovative treatments for multiple diseases
13:33
Nov18
Anavex Life Science to Release FY2025 Q4 Earnings on November 25 During-Market EST, Forecast Revenue USD 0, EPS USD -0.15
00:06
Nov14
Anavex Life Sciences faces negative vote from EMA's CHMP and requests re-examination
13:02

Schedules & Filings

Schedules
Filings
Nov25
Earning Release(EST)

FY2025 Q4 Earning Release (USD) Net Income -9.827 M, EPS -0.1144

Aug12
Earning Release(EST)

FY2025 Q3 Earning Release (USD) Net Income -13.24 M, EPS -0.1551

May13
Earning Release(EST)

FY2025 Q2 Earning Release (USD) Net Income -11.2 M, EPS -0.1316

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
TGL
18.460
+173.16%
+11.702
SMX
292.370
+107.35%
+150.560
GURE
8.980
+89.45%
+4.240
WHLR
5.610
+73.15%
+2.397
DBRG
13.987
+43.90%
+4.255
IRBT
4.205
+38.78%
+1.178
TDIC
0.3799
+35.29%
+0.099
LICN
3.869
+32.05%
+0.939
TORO
5.450
+31.96%
+1.320
ALMS
10.920
+31.57%
+2.620
View More